Skip to content
10-Q

Quarterly Report

Ocera Therapeutics, Inc.

0001274644-16-000150

← back to feed
Filed
Nov 2, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Oct 31, 2016 23.14M sh
Stockholders Equity Q3 2016 · Sep 30, 2016 $18.85M
Stockholders Equity Q3 2016 · Dec 31, 2015 $31.39M
Current Liabilities Q3 2016 · Sep 30, 2016 $7.27M
Current Liabilities Q3 2016 · Dec 31, 2015 $3.83M
Total Liabilities Q3 2016 · Sep 30, 2016 $15.09M
Total Liabilities Q3 2016 · Dec 31, 2015 $13.34M
Current Assets Q3 2016 · Sep 30, 2016 $33.24M
Current Assets Q3 2016 · Dec 31, 2015 $44.02M
Total Assets Q3 2016 · Sep 30, 2016 $33.93M
Total Assets Q3 2016 · Dec 31, 2015 $44.74M
Capex Q3 2016 · Sep 30, 2015 $71K
Operating Cash Flow Q3 2016 · Sep 30, 2015 −$15.13M
Cash And Equivalents Q3 2016 · Sep 30, 2015 $22.77M
Cash And Equivalents Q3 2016 · Dec 31, 2014 $10.13M
Sga Expense Q3 2016 · Sep 30, 2015 $2.37M
Sga Expense Q3 2016 · Sep 30, 2015 $7.46M
Rd Expense Q3 2016 · Sep 30, 2015 $4.24M
Rd Expense Q3 2016 · Sep 30, 2015 $12.05M
Net Income Q3 2016 · Sep 30, 2015 −$6.57M
Net Income Q3 2016 · Sep 30, 2015 −$19.45M